ABC transporters as differentiation markers in glioblastoma cells

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells

(2013) Anna Golebiewska et al.   BRAIN

Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures

(2013) Elisa Carra et al.   CELL CYCLE

Prognostic significance of MRP5 immunohistochemical expression in glioblastoma

(2012) George A. Alexiou et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Bioimpedance analysis and cardiovascular status in pediatric patients on chronic hemodialysis

(2012) Fabio Paglialonga et al.   Hemodialysis International

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures

(2012) Sandrine Eimer et al.   NEURO-ONCOLOGY

The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas

(2012) Janka Held-Feindt et al.   NEUROCHEMISTRY INTERNATIONAL

ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma

(2012) Tony Huynh et al.   Frontiers in Oncology

Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo

(2011) L Nogueira et al.   ONCOGENE

Drug Efflux Transporter Multidrug Resistance-Associated Protein 5 Affects Sensitivity of Pancreatic Cancer Cell Lines to the Nucleoside Anticancer Drug 5-Fluorouracil

(2010) P. K. Nambaru et al.   DRUG METABOLISM AND DISPOSITION

Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma

(2009) Eiichi Nakai et al.   CANCER INVESTIGATION

Better results with the new generation bare metal stents

(2009) Harald Vik-Mo   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells

(2009) Audun O Vik-Mo et al.   BMC Pharmacology & Toxicology